February 17, 2026
1 min read

Novartis taps Niowave for long-term supply of radiopharmaceutical isotope

The clamor for radioisotopes has continued into the new year, with Novartis inking a deal with radiopharmaceutical producer Niowave to supply the pharma giant with the specialized ingredient Actinium-225 (Ac-225) used to develop targeted cancer therapies.

Leave a Reply

Your email address will not be published.

Previous Story

Free Nutrition Counseling Sign-Up

Next Story

Abortion Restrictions Increase Deaths Among Expecting And New Moms, Researchers Report MedNews

Previous Story

Free Nutrition Counseling Sign-Up

Next Story

Abortion Restrictions Increase Deaths Among Expecting And New Moms, Researchers Report MedNews

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop